BACKGROUND AND OBJECTIVE
Cancer pain affects 55-95% of patients with advanced malignancy and remains inadequately controlled in approximately two-thirds of those with metastatic disease. Management is shifting toward a multimodal, mechanism-based and personalised approach. This narrative review summarises current evide...
Giuliano Lo Bianco, A. Abd-Elsayed, S. Mercadante· Annals of Palliative Medicin...· 0 citations
Background and Objectives: Orthobiologic injectables—principally platelet-rich plasma (PRP), bone marrow aspirate concentrate (BMAC), cell-based therapies and, increasingly, extracellular vesicles—are widely used for chronic musculoskeletal (MSK) pain, yet their evidence base is inconsistent and guideline endorsement i...
Giuliano Lo Bianco, Douglas P. Beall, Sudhir Diwan et al.· Medicina· 0 citations
Future progress in SCS will likely depend on artificial intelligence, remote monitoring, biomarker-guided programming, and integration with multidisciplinary chronic pain care.
Nafay Abdul, Milan Patel, Rohit Aiyer et al.· Journal of Clinical Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.